サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1765431

経カテーテル塞栓術および閉塞装置の世界市場

Transcatheter Embolization and Occlusion Devices

出版日
ページ情報
英文 193 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.02円
経カテーテル塞栓術および閉塞装置の世界市場
出版日: 2025年07月09日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 193 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

経カテーテル塞栓術および閉塞装置の世界市場は2030年までに68億米ドルに達する見込み

2024年に46億米ドルと推定される経カテーテル塞栓術および閉塞装置の世界市場は、2024年から2030年にかけてCAGR 6.6%で成長し、2030年には68億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである塞栓コイルは、CAGR 7.1%を記録し、分析期間終了時には28億米ドルに達すると予測されます。コイリングアシストデバイス分野の成長率は、分析期間中CAGR 5.9％と推定されます。

米国市場は13億米ドルと推定、中国はCAGR6.1％で成長予測

米国の経カテーテル塞栓術および閉塞装置市場は2024年に13億米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを6.1%として、2030年までに10億米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ6.2％と5.2％と予測されています。欧州では、ドイツがCAGR 5.4%で成長すると予測されています。

世界の経カテーテル塞栓術および閉塞装置市場- 主要動向と促進要因のまとめ

経カテーテル塞栓術および閉塞装置とは何か、なぜ医療現場で重要なのか？

経カテーテル塞栓術および閉塞装置とは、主にインターベンショナルラジオロジーや低侵襲手術など、様々な治療用途で血管を遮断・閉塞するために使用される医療器具です。動脈瘤、動静脈奇形（AVM）、腫瘍、異常出血などの治療に用いられます。これらの器具の主な目的は、標的部位への血流を阻止することで、治療を容易にし、外科手術中の合併症のリスクを軽減することです。血管の状態を管理する上で重要な役割を果たすこれらの器具は、現代のヘルスケアにおいて不可欠なツールであり、従来の手術に比べて侵襲性の低い治療法を患者に提供します。

経カテーテル塞栓術および閉塞装置の世界の普及は、血管疾患の有病率の増加、インターベンション技術の進歩、低侵襲手術に対する需要の高まりによってもたらされています。世界的に高齢化が進み、動脈瘤、がん、末梢血管疾患などの罹患率が上昇するにつれて、効果的な塞栓術や閉塞術の必要性が高まっています。さらに、画像技術やカテーテルを用いた手技の進歩により、これらの手技の安全性と有効性が向上しており、ヘルスケア提供者に経カテーテル的手技の採用を促しています。侵襲性の低い介入によって患者の予後を改善することに重点が置かれていることが、世界の経カテーテル塞栓術および閉塞装置市場の拡大を後押ししています。

技術の進歩は経カテーテル塞栓術および閉塞装置の開発をどのように形成しているか？

技術の進歩は、経カテーテル塞栓術および閉塞装置のデザインと機能性を大幅に向上させ、医療処置における転帰の改善と効率の向上をもたらしています。注目すべき技術革新のひとつは、塞栓デバイスのための生体吸収性・生分解性材料の開発です。これらの先端材料は血管の一時的な閉塞を可能にし、永久的なインプラントに伴う長期的な合併症のリスクを軽減します。生体吸収性デバイスの使用により、治癒後は正常な血流が回復するため、血管病変やその他の病態を管理する上で大きな利点となります。

市場を牽引するもう一つの重要な技術的進歩は、経カテーテル治療と高度な画像診断技術の統合です。コーンビームCT（CBCT）や術中超音波などの技術は、塞栓術中の可視化と精度の向上に利用されています。このような画像診断能力の向上は、血管解剖のより良い評価と塞栓装置のより正確な配置を可能にし、最終的には手技の成功率の向上につながります。高度な画像診断と経カテーテル技術の組み合わせは、塞栓術や閉塞術へのアプローチに革命をもたらし、患者にとってより安全で効果的な塞栓術を可能にしています。

さらに、ハイブリッド機器や多機能機器の開発により、経カテーテル塞栓システムの機能が拡大しています。メーカー各社は、塞栓剤を送達すると同時に他の治療的介入を可能にするなど、多機能を発揮する装置の開発にますます力を注いでいます。このような機能の統合は、手技を合理化し、複数の装置の必要性を減らし、最終的には効率を高め、患者ケアを向上させる。多機能性と革新性を重視することが経カテーテル塞栓術および閉塞装置の将来を形成し、複雑な血管状態に対処するためのより汎用性の高いツールをヘルスケア専門家に提供しています。

様々なヘルスケアシーンで経カテーテル塞栓術および閉塞装置が採用されている要因は何ですか？

経カテーテル塞栓術および閉塞装置の採用は、血管疾患の有病率の増加、低侵襲処置の需要の高まり、患者の安全性とアウトカムへの関心の高まりなど、いくつかの重要な要因によって推進されています。主な原動力の1つは、動脈瘤や末梢動脈疾患などの血管疾患の有病率の増加であり、これらは効果的な治療オプションを必要としています。高齢化社会と慢性疾患の発生率が上昇を続ける中、これらの病態を安全かつ効果的に管理できる経カテーテル的ソリューションに対する需要が高まっています。ヘルスケアプロバイダーは、患者を治療するために塞栓・閉塞装置への依存度を高めており、それによって市場導入が促進されています。

経カテーテル塞栓術および閉塞装置の採用に影響を与えるもう一つの重要な要因は、低侵襲手技に対する需要の高まりです。患者やヘルスケア専門家は、外科的外傷を減らし、回復時間を短縮し、合併症を最小限に抑える技術をますます好むようになっています。経カテーテル的手技は、入院期間の短縮や回復の早さなど大きな利点があり、患者と医療従事者の双方にとって魅力的な選択肢となっています。このような低侵襲アプローチへのシフトは、開腹手術を必要とせずに血管問題を治療する効果的なソリューションを提供する塞栓・閉塞装置の採用を促進しています。

さらに、患者の安全性と臨床転帰の改善への関心の高まりが、さまざまなヘルスケア現場での経カテーテル塞栓術および閉塞装置の採用を促進しています。ヘルスケアプロバイダーが安全性を高め、リスクを最小化する機器の使用を優先するにつれ、高度な塞栓・閉塞ソリューションへの需要が高まっています。より安全で効果的な機器の開発と、その使用に関するトレーニングやプロトコルの改善は、患者の転帰の改善と満足度の向上に寄与しています。このように安全性と質の高い医療が重視されることで、ヘルスケア施設は経カテーテル塞栓術および閉塞装置をより広く採用するようになっています。

経カテーテル塞栓術および閉塞装置の世界市場成長の原動力は？

世界の経カテーテル塞栓術および閉塞装置市場の成長は、ヘルスケアインフラへの投資の増加、医療技術の進歩の増加、個別化医療への動向の高まりなど、いくつかの要因によって牽引されています。主な成長要因の1つは、患者ケアの向上と先進医療へのアクセス拡大を目的としたヘルスケアインフラへの投資の増加です。政府およびヘルスケア機関は、特に新興経済国において、医療施設のアップグレードにリソースを割くようになっており、インターベンショナル・ラジオロジーおよび塞栓術の採用が増加しています。血管疾患の効果的な治療に対する需要がヘルスケア・インフラへの投資を促進し、経カテーテル塞栓術および閉塞装置市場の成長を支えています。

市場成長のもう一つの大きな促進要因は、経カテーテル手技の有効性と安全性を高める医療技術の進歩が進んでいることです。革新的な塞栓材料、改良された画像技術、高度な送達システムの開発により、ヘルスケアプロバイダーはより高い精度と信頼性をもって手技を実施できるようになっています。メーカーが研究開発への投資を続け、性能と患者の予後を改善する新製品を開発するにつれて、経カテーテル塞栓術および閉塞装置の需要は高まることが予想されます。このような技術革新への注力は、競合情勢の中で各社が提供する製品の差別化を図り、市場の成長を促進しています。

さらに、個別化医療への動向の高まりが経カテーテル塞栓術および閉塞装置市場の成長を支えています。ヘルスケアがより個別化された治療アプローチに移行するにつれて、ターゲットを絞った効果的な塞栓ソリューションの必要性がますます高まっています。経カテーテル装置は、患者固有の解剖学的特徴や臨床的特徴を考慮して、患者の特定のニーズに合わせて調整することができます。このような個別化治療への注目は、医療従事者が治療効果を高め、患者の転帰を改善しようとする中で、経カテーテルソリューションの採用を後押ししています。

さらに、医療従事者や患者の間で低侵襲技術とその利点に対する認識が高まっていることも、経カテーテル塞栓術および閉塞装置市場の成長に影響を与えています。血管疾患の治療に経カテーテル法を用いることの利点を認識する開業医が増えるにつれて、これらのデバイスの採用は増加すると予想されます。手術手技と患者の安全性を向上させることが重視され、ヘルスケア施設は先進的な経カテーテル塞栓術および閉塞装置への投資を進めています。このような要因が市場展望を形成し続ける中、医療インフラへの投資の増加、医療技術の進歩の増加、個別化医療への傾向の高まりによって、市場情勢は力強い成長を遂げようとしています。

セグメント

製品タイプ（塞栓用コイル、コイリングアシストデバイス、塞栓用粒子、流体迂回デバイス、液体塞栓、アクセサリー）

調査対象企業の例

  • Abbott Laboratories
  • Boston Scientific Corporation
  • BTG International Ltd.
  • Cook Medical LLC
  • Edwards Lifesciences Corporation
  • Johnson & Johnson
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Penumbra, Inc.
  • Pfizer, Inc.
  • Sirtex Medical Limited
  • Stryker Corporation
  • Terumo Corporation

AIインテグレーション

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家からキュレートされたコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP16866

Global Transcatheter Embolization and Occlusion Devices Market to Reach US$6.8 Billion by 2030

The global market for Transcatheter Embolization and Occlusion Devices estimated at US$4.6 Billion in the year 2024, is expected to reach US$6.8 Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2024-2030. Embolization Coils, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$2.8 Billion by the end of the analysis period. Growth in the Coiling Assist Devices segment is estimated at 5.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.3 Billion While China is Forecast to Grow at 6.1% CAGR

The Transcatheter Embolization and Occlusion Devices market in the U.S. is estimated at US$1.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.0 Billion by the year 2030 trailing a CAGR of 6.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.2% and 5.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR.

Global Transcatheter Embolization and Occlusion Devices Market - Key Trends & Drivers Summarized

What Are Transcatheter Embolization and Occlusion Devices and Why Are They Critical in Medical Procedures?

Transcatheter embolization and occlusion devices are medical instruments used to block or occlude blood vessels in various therapeutic applications, primarily in interventional radiology and minimally invasive surgery. These devices include a range of products such as embolic agents (coils, particles, and gels) and occlusion balloons, which are employed to treat conditions like aneurysms, arteriovenous malformations (AVMs), tumors, and abnormal bleeding. The primary purpose of these devices is to prevent blood flow to targeted areas, thereby facilitating treatment and reducing the risk of complications during surgical procedures. Their critical role in managing vascular conditions makes them essential tools in modern healthcare, offering patients less invasive treatment options compared to traditional surgery.

The global adoption of transcatheter embolization and occlusion devices is driven by the increasing prevalence of vascular diseases, advancements in interventional techniques, and the growing demand for minimally invasive procedures. As the global population ages and the incidence of conditions such as aneurysms, cancer, and peripheral vascular disease rises, the need for effective embolization and occlusion solutions has become more pronounced. Additionally, ongoing advancements in imaging technologies and catheter-based techniques have enhanced the safety and efficacy of these procedures, encouraging healthcare providers to adopt transcatheter methods. The emphasis on improving patient outcomes through less invasive interventions is propelling the expansion of the global transcatheter embolization and occlusion devices market.

How Are Technological Advancements Shaping the Development of Transcatheter Embolization and Occlusion Devices?

Technological advancements are significantly enhancing the design and functionality of transcatheter embolization and occlusion devices, leading to improved outcomes and greater efficiency in medical procedures. One notable innovation is the development of bioresorbable and biodegradable materials for embolic devices. These advanced materials allow for temporary occlusion of blood vessels, reducing the risk of long-term complications associated with permanent implants. The use of bioresorbable devices enables the restoration of normal blood flow once healing has occurred, providing a significant advantage in managing vascular lesions and other conditions.

Another key technological advancement driving the market is the integration of advanced imaging techniques with transcatheter procedures. Technologies such as cone beam computed tomography (CBCT) and intraoperative ultrasound are being utilized to enhance visualization and precision during embolization procedures. This improved imaging capability allows for better assessment of vascular anatomy and more accurate placement of embolic devices, ultimately leading to increased procedural success rates. The combination of advanced imaging and transcatheter techniques is revolutionizing the approach to embolization and occlusion, making these devices safer and more effective for patients.

Furthermore, the development of hybrid and multifunctional devices is expanding the capabilities of transcatheter embolization systems. Manufacturers are increasingly focusing on creating devices that can perform multiple functions, such as delivering embolic agents while simultaneously providing access for other therapeutic interventions. This integration of functions can streamline procedures and reduce the need for multiple devices, ultimately enhancing efficiency and improving patient care. The emphasis on multifunctionality and innovation is shaping the future of transcatheter embolization and occlusion devices, providing healthcare professionals with more versatile tools to address complex vascular conditions.

What Factors Are Driving the Adoption of Transcatheter Embolization and Occlusion Devices Across Various Healthcare Settings?

The adoption of transcatheter embolization and occlusion devices is being driven by several key factors, including the increasing prevalence of vascular diseases, the rising demand for minimally invasive procedures, and the growing focus on patient safety and outcomes. One of the primary drivers is the increasing prevalence of vascular diseases, such as aneurysms and peripheral artery disease, which require effective treatment options. As the aging population and the incidence of chronic diseases continue to rise, the demand for transcatheter solutions that can safely and effectively manage these conditions is escalating. Healthcare providers are increasingly relying on embolization and occlusion devices to treat patients, thereby driving market adoption.

Another significant factor influencing the adoption of transcatheter embolization and occlusion devices is the rising demand for minimally invasive procedures. Patients and healthcare professionals are increasingly favoring techniques that reduce surgical trauma, shorten recovery times, and minimize complications. Transcatheter procedures offer significant benefits, including reduced hospital stays and faster recuperation, making them appealing options for both patients and providers. This shift towards minimally invasive approaches is driving the adoption of embolization and occlusion devices, as they provide effective solutions for treating vascular issues without the need for open surgery.

Moreover, the growing focus on patient safety and improved clinical outcomes is driving the adoption of transcatheter embolization and occlusion devices across various healthcare settings. As healthcare providers prioritize the use of devices that enhance safety and minimize risks, the demand for advanced embolization and occlusion solutions is increasing. The development of safer and more effective devices, along with improved training and protocols for their use, is contributing to better patient outcomes and higher satisfaction rates. This emphasis on safety and quality care is encouraging healthcare facilities to adopt transcatheter embolization and occlusion devices more widely.

What Is Driving the Growth of the Global Transcatheter Embolization and Occlusion Devices Market?

The growth in the global Transcatheter Embolization and Occlusion Devices market is driven by several factors, including rising investments in healthcare infrastructure, increasing advancements in medical technologies, and the growing trend towards personalized medicine. One of the primary growth drivers is the rising investment in healthcare infrastructure aimed at improving patient care and expanding access to advanced medical treatments. Governments and healthcare organizations are increasingly allocating resources to upgrade medical facilities, particularly in emerging economies, leading to an increased adoption of interventional radiology and embolization techniques. The demand for effective treatment of vascular conditions is driving investments in healthcare infrastructure, thereby supporting the growth of the transcatheter embolization and occlusion devices market.

Another significant driver of market growth is the increasing advancements in medical technologies that enhance the efficacy and safety of transcatheter procedures. The development of innovative embolization materials, improved imaging technologies, and advanced delivery systems is enabling healthcare providers to perform procedures with greater precision and confidence. As manufacturers continue to invest in R&D and develop new products that offer improved performance and patient outcomes, the demand for transcatheter embolization and occlusion devices is expected to rise. This focus on innovation is fostering market growth as companies seek to differentiate their offerings in a competitive landscape.

Moreover, the growing trend towards personalized medicine is supporting the growth of the transcatheter embolization and occlusion devices market. As healthcare moves towards more individualized treatment approaches, the need for targeted and effective embolization solutions is becoming increasingly important. Transcatheter devices can be tailored to meet the specific needs of patients, taking into account their unique anatomical and clinical characteristics. This focus on personalized care is driving the adoption of transcatheter solutions, as healthcare providers seek to enhance treatment efficacy and improve patient outcomes.

Furthermore, the increasing awareness of minimally invasive techniques and their benefits among healthcare providers and patients is influencing the growth of the transcatheter embolization and occlusion devices market. As more practitioners recognize the advantages of using transcatheter methods to treat vascular conditions, the adoption of these devices is expected to increase. The emphasis on improving surgical techniques and patient safety is driving healthcare facilities to invest in advanced transcatheter embolization and occlusion devices. As these factors continue to shape the market landscape, the transcatheter embolization and occlusion devices market is poised for robust growth, driven by rising investments in healthcare infrastructure, increasing advancements in medical technologies, and a growing trend towards personalized medicine.

SCOPE OF STUDY:

The report analyzes the Transcatheter Embolization and Occlusion Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics, Accessories)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

  • Abbott Laboratories
  • Boston Scientific Corporation
  • BTG International Ltd.
  • Cook Medical LLC
  • Edwards Lifesciences Corporation
  • Johnson & Johnson
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Penumbra, Inc.
  • Pfizer, Inc.
  • Sirtex Medical Limited
  • Stryker Corporation
  • Terumo Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Transcatheter Embolization and Occlusion Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Vascular Disorders and Aneurysms Drives Demand for Transcatheter Embolization and Occlusion Devices
    • Increased Adoption of Minimally Invasive Surgeries Expands Addressable Market for Transcatheter Embolization Devices
    • Surge in Demand for Transcatheter Embolization Devices in Cancer and Tumor Treatments Fuels Market Growth
    • Increased Use of Transcatheter Embolization Devices in Trauma and Emergency Care Settings Fuels Market Expansion
    • Technological Innovations in Bioabsorbable and Biocompatible Embolic Devices Propel Market Growth
    • Growing Use of Transcatheter Embolization Devices in Stroke Management and Neurovascular Interventions Strengthens Business Case
    • Surge in Adoption of Transcatheter Occlusion Devices in Congenital Heart Defect Treatments Fuels Market Demand
    • Rising Adoption of Transcatheter Devices in Liver and Kidney Tumor Embolization Expands Market Opportunities
    • Rising Use of Transcatheter Embolization Devices in Postpartum Hemorrhage and Uterine Fibroid Embolization Strengthens Business Case
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Transcatheter Embolization and Occlusion Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Transcatheter Embolization and Occlusion Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Embolization Coils by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Embolization Coils by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Embolization Coils by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Coiling Assist Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Coiling Assist Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Coiling Assist Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Embolization Particles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Embolization Particles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Embolization Particles by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Flow Diverting Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Flow Diverting Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Flow Diverting Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Liquid Embolics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Liquid Embolics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Liquid Embolics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Transcatheter Embolization and Occlusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Product Type - Percentage Breakdown of Value Sales for Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Product Type - Percentage Breakdown of Value Sales for Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories for the Years 2015, 2025 & 2030
  • JAPAN
    • Transcatheter Embolization and Occlusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Japan 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Product Type - Percentage Breakdown of Value Sales for Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories for the Years 2015, 2025 & 2030
  • CHINA
    • Transcatheter Embolization and Occlusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 32: China Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: China Historic Review for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: China 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Product Type - Percentage Breakdown of Value Sales for Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories for the Years 2015, 2025 & 2030
  • EUROPE
    • Transcatheter Embolization and Occlusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 35: Europe Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: Europe Historic Review for Transcatheter Embolization and Occlusion Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Europe 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Europe Historic Review for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Europe 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Product Type - Percentage Breakdown of Value Sales for Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories for the Years 2015, 2025 & 2030
  • FRANCE
    • Transcatheter Embolization and Occlusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 41: France Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: France Historic Review for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: France 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Product Type - Percentage Breakdown of Value Sales for Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories for the Years 2015, 2025 & 2030
  • GERMANY
    • Transcatheter Embolization and Occlusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 44: Germany Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Germany Historic Review for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Germany 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Product Type - Percentage Breakdown of Value Sales for Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 47: Italy Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Italy Historic Review for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Italy 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Product Type - Percentage Breakdown of Value Sales for Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Transcatheter Embolization and Occlusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 50: UK Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: UK Historic Review for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: UK 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Product Type - Percentage Breakdown of Value Sales for Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 53: Rest of Europe Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Rest of Europe Historic Review for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Rest of Europe 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Product Type - Percentage Breakdown of Value Sales for Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Transcatheter Embolization and Occlusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Asia-Pacific 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Product Type - Percentage Breakdown of Value Sales for Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 59: Rest of World Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Rest of World Historic Review for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Rest of World 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Product Type - Percentage Breakdown of Value Sales for Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories for the Years 2015, 2025 & 2030

IV. COMPETITION